Form D · Biotechnology
Enosi Life Sciences Corp.
San Diego, CA · CIK 0001822263
Offering snapshot reported Sep 1, 2020 · SEC filing
- Reported sold
- Yet to sell Offering amount: $8M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 1, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $160K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-374551
The Company has entered into an agreement with Dalmore Group, LLC who will act as broker-dealer and receive 2.0% of the dollar value of the shares sold to all Investors as a commission.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Dalmore Group LLC | 136352 |
Source: Form D, filed Sep 1, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marc Feldmann | Director |
| Ozan Pamir | Executive |
| H. Michael Shepard | Executive |
| James Woody | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12707 High Bluff Drive, Suite 200
San Diego, CA, 92130-2035
San Diego, CA, 92130-2035